Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Maternal vaccination against nicotine reduces nicotine distribution to fetal brain in rats.

Keyler DE, Shoeman D, LeSage MG, Calvin AD, Pentel PR.

J Pharmacol Exp Ther. 2003 May;305(2):587-92. Epub 2003 Feb 11.

PMID:
12606612
2.

Protection of superoxide-induced cholesterol oxidation by antioxidants in protic conditions.

Csallany AS, Hee-Lee J, Shoeman DW.

Int J Food Sci Nutr. 2002 Sep;53(5):403-9.

PMID:
12396465
3.

Acetaminophen-induced suppression of hepatic AdoMet synthetase activity is attenuated by prodrugs of L-cysteine.

Shirota FN, DeMaster EG, Shoeman DW, Nagasawa HT.

Toxicol Lett. 2002 Jun 7;132(1):1-8.

PMID:
12084614
4.

Continuous nicotine infusion reduces nicotine self-administration in rats with 23-h/day access to nicotine.

LeSage MG, Keyler DE, Shoeman D, Raphael D, Collins G, Pentel PR.

Pharmacol Biochem Behav. 2002 May;72(1-2):279-89.

PMID:
11900798
5.

N-hydroxybenzenecarboximidic acid derivatives: a new class of nitroxyl-generating prodrugs.

Lee MJ, Shoeman DW, Goon DJ, Nagasawa HT.

Nitric Oxide. 2001 Jun;5(3):278-87.

PMID:
11384201
6.

Agmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury.

Fairbanks CA, Schreiber KL, Brewer KL, Yu CG, Stone LS, Kitto KF, Nguyen HO, Grocholski BM, Shoeman DW, Kehl LJ, Regunathan S, Reis DJ, Yezierski RP, Wilcox GL.

Proc Natl Acad Sci U S A. 2000 Sep 12;97(19):10584-9.

7.

Reaction of nitroxyl, an aldehyde dehydrogenase inhibitor, with N-acetyl-L-cysteine.

Shoeman DW, Shirota FN, DeMaster EG, Nagasawa HT.

Alcohol. 2000 Jan;20(1):55-9.

PMID:
10680717
8.
9.

Reaction between S-nitrosothiols and thiols: generation of nitroxyl (HNO) and subsequent chemistry.

Wong PS, Hyun J, Fukuto JM, Shirota FN, DeMaster EG, Shoeman DW, Nagasawa HT.

Biochemistry. 1998 Apr 21;37(16):5362-71.

PMID:
9548918
10.

The effect of superoxide anion in the production of seven major cholesterol oxidation products in aptoric and protic conditions.

Lee JH, Shoeman DW, Kim SS, Csallany AS.

Int J Food Sci Nutr. 1997 Mar;48(2):151-9.

PMID:
9135779
11.

Protection against acetaminophen-induced hepatotoxicity by L-CySSME and its N-acetyl and ethyl ester derivatives.

Nagasawa HT, Shoeman DW, Cohen JF, Rathbun WB.

J Biochem Toxicol. 1996;11(6):289-95.

PMID:
9176740
12.
13.

Diabetes increases excretion of urinary malonaldehyde conjugates in rats.

Gallaher DD, Csallany AS, Shoeman DW, Olson JM.

Lipids. 1993 Jul;28(7):663-6.

PMID:
8355596
14.

Urinary response to in vivo lipid peroxidation induced by vitamin E deficiency.

Lee HS, Shoeman DW, Csallany AS.

Lipids. 1992 Feb;27(2):124-8.

PMID:
1579056
15.
16.

Measurement of hydroperoxydocosahexaenoic acid in rat brain homogenates by reversed-phase high-performance liquid chromatography.

Ansari KA, Shoeman DW.

J Chromatogr. 1989 Jul 28;475:457-60. No abstract available.

PMID:
2528565
17.

Age-related changes in lipid peroxidation and protective enzymes in the central nervous system.

Ansari KA, Kaplan E, Shoeman D.

Growth Dev Aging. 1989 Autumn;53(3):117-21.

PMID:
2599741
18.

Rapid separation of free fatty acids from neutral lipids in brain extracts.

Ansari KA, Shoeman D.

J Chromatogr. 1988 May 20;439(2):453-8. No abstract available.

PMID:
2969915
19.

The medical computing curriculum at the University of New England College of Osteopathic Medicine.

Yonuschot G, Shoeman D.

J Am Osteopath Assoc. 1985 Apr;85(4):264-7. No abstract available.

PMID:
3840145
20.

Quantitation of chlordiazepoxide and its metabolites in biological fluids by thin-layer chromatography.

Straughan JL, Cathcart-Rake WF, Shoeman DW, Azarnoff DL.

J Chromatogr. 1978 Nov 1;146(3):473-80.

PMID:
363736
21.

Correlation between plasma diphenhydramine level and sedative and antihistamine effects.

Carruthers SG, Shoeman DW, Hignite CE, Azarnoff DL.

Clin Pharmacol Ther. 1978 Apr;23(4):375-82.

PMID:
24512
22.

Glutethimide and 4-OH glutethimide: pharmacokinetics and effect on performance in man.

Crow JW, Lain P, Bochner F, Shoeman DW, Azarnoff DL.

Clin Pharmacol Ther. 1977 Oct;22(4):458-64.

PMID:
902458
23.

Acute toxicity of benzene inhalation to hemopoietic precursor cells.

Uyeki EM, Ashkar AE, Shoeman DW, Bisel TU.

Toxicol Appl Pharmacol. 1977 Apr;40(1):49-57. No abstract available.

PMID:
867432
24.

The interaction between halofenate and propranolol.

Huffman DH, Azarnoff DL, Shoeman DW, Dujovne CA.

Clin Pharmacol Ther. 1976 Jun;19(6):807-12.

PMID:
773588
25.

Liver cell culture toxicity of general anesthetics.

Goto Y, Dujovne CA, Shoeman DW, Arakawa K.

Toxicol Appl Pharmacol. 1976 Apr;36(1):121-30. No abstract available.

PMID:
1273833
26.

Hepatotoxicity of general anesthetics on rat hepatoma cells in culture.

Goto Y, Dujovne CA, Shoeman DW, Arakawa K, Klaassen CD.

Proc Soc Exp Biol Med. 1976 Apr;151(4):789-94. No abstract available.

PMID:
177989
27.

One-year trials with halofenate, clofibrate, and placebo.

Dujovne CA, Azarnoff DL, Huffman DH, Pentikäinen P, Hurwitz A, Shoeman DW.

Clin Pharmacol Ther. 1976 Mar;19(3):352-9.

PMID:
177242
28.

Proceedings: Pharmacokinetics of drugs in patients with nephrotic syndrome.

Azarnoff DL, Gugler R, Shoeman DW, Huffman DH, Cohlmia J.

Arzneimittelforschung. 1976;26(6):1267-8. No abstract available.

PMID:
989463
29.

Diphenylhydantoin potency and plasma protein binding.

Shoeman DW, Azarnoff DL.

J Pharmacol Exp Ther. 1975 Oct;195(1):84-6.

PMID:
1181407
30.

Pharmacokinetics of drugs in patients with the nephrotic syndrome.

Gugler R, Shoeman DW, Huffman DH, Cohlmia JB, Azarnoff DL.

J Clin Invest. 1975 Jun;55(6):1182-9.

31.

Diphenylhydantoin: correlation between protein binding and albumin concentration.

Gugler R, Azarnoff DL, Shoeman DW.

Klin Wochenschr. 1975 May 1;53(9):445-6.

PMID:
1152355
32.

Separation and quantitative analysis of furosemide and 4-chloro-5-sulfamoylanthranilic adid (CSA) by high pressure liquid chromatography.

MacDougall ML, Shoeman DW, Azarnoff DL.

Res Commun Chem Pathol Pharmacol. 1975 Feb;10(2):285-92.

PMID:
1153837
33.

High-pressure liquid chromatographic assay of theophylline in biological fluids.

Manion CV, Shoeman DW, Azarnoff DL.

J Chromatogr. 1974 Dec 4;101(1):169-74. No abstract available.

PMID:
4443381
34.

Inhibition of amphetamine tolerance and metabolism by propranolol.

Shoeman DW, Sirtori CR, Azarnoff DL.

J Pharmacol Exp Ther. 1974 Oct;191(1):68-71. No abstract available.

PMID:
4418151
35.

Biliary excretion of lead in rats, rabbits, and dogs.

Klaassen CD, Shoeman DW.

Toxicol Appl Pharmacol. 1974 Sep;29(3):434-46. No abstract available.

PMID:
4283706
36.

Correlation of the plasma elimination of antipyrine and the appearance of 4-hydroxy antipyrine in the urine of man.

Huffman DH, Shoeman DW, Azarnoff DL.

Biochem Pharmacol. 1974 Jan 15;23(2):197-201. No abstract available.

PMID:
4813341
37.

Effect of in vivo elevation of free fatty acids on protein binding of drugs.

Gugler R, Shoeman DW, Azarnoff DL.

Pharmacology. 1974;12(3):160-5. No abstract available.

PMID:
4445192
38.

The alteration of plasma proteins in uremia as reflected in the ability to bind diphenylhydantoin.

Shoeman DW, Benjamin DM, Azarnoff DL.

Ann N Y Acad Sci. 1973 Nov 26;226:127-30. No abstract available.

PMID:
4520391
39.

Surfactant laxatives and hepatotoxicity.

Dnjovne CA, Shoeman DW.

Ann Intern Med. 1973 Jul;79(1):137-8. No abstract available.

PMID:
4721166
40.

Induction of drug metabolism. VII. Differences in P-420 hemoproteins from untreated and 3-methylcholanthrene-treated rats.

Shoeman DW, Vane FM, Mannering GJ.

Mol Pharmacol. 1973 May;9(3):373-82. No abstract available.

PMID:
4710137
41.

Differences in P-450 cytochromes from livers of rats treated with phenobarbital and with 3-methylcholanthrene.

Fujita T, Shoeman DW, Mannering GJ.

J Biol Chem. 1973 Mar 25;248(6):2192-201. No abstract available.

42.

The effect of spironolactone on antipyrine metabolism in man.

Huffman DH, Shoeman DW, Pentikäinen P, Azarnoff DL.

Pharmacology. 1973;10(6):338-44. No abstract available.

PMID:
4593769
43.

Differences in P-420 hemoproteins from untreated and 3-methylcholanthrene-treated rats.

Shoeman DW, Vane FM, Mannering GJ.

Drug Metab Dispos. 1973 Jan-Feb;1(1):40-4. No abstract available.

PMID:
4149411
44.

Absorption and excretion of clindamycin-2-phosphate in children after intramuscular injection.

Kauffman RE, Shoeman DW, Suk-Han-Wan, Azarnoff DL.

Clin Pharmacol Ther. 1972 Sep-Oct;13(5):704-9. No abstract available.

PMID:
5053811
45.

Toxicity of a hepatotoxic laxative preparation in tissue culture and excretion in bile in man.

Dujovne CA, Shoeman DW.

Clin Pharmacol Ther. 1972 Jul-Aug;13(4):602-8. No abstract available.

PMID:
5042373
46.

Placental transfer of diphenylhydantoin in the goat.

Shoeman DW, Kauffman RE, Azarnoff DL, Boulos BM.

Biochem Pharmacol. 1972 May 1;21(9):1237-43. No abstract available.

PMID:
5064576
47.

Serum digitoxin in uremic patients.

Shoeman DW, Azarnoff DL.

Clin Pharmacol Ther. 1972 May-Jun;13(3):460. No abstract available.

PMID:
5026385
48.

Experimental bases for the different hepatotoxicity of erythromycin preparations in man.

Dujovne CA, Shoeman D, Bianchine J, Lasagna L.

J Lab Clin Med. 1972 May;79(5):832-44. No abstract available.

PMID:
5018747
49.

Evidence that inhibition of hepatic drug oxidation by tumors is mediated by a circulating humor.

Boulos BM, MacDougall M, Shoeman DW, Azarnoff DL.

Proc Soc Exp Biol Med. 1972 Apr;139(4):1353-5. No abstract available.

PMID:
5023334
50.

The alteration of plasma proteins in uremia as reflected in their ability to bind digitoxin and diphenylhydantoin.

Shoeman DW, Azarnoff DL.

Pharmacology. 1972;7(3):169-77. No abstract available.

PMID:
5054587

Supplemental Content

Loading ...
Support Center